129 related articles for article (PubMed ID: 31646036)
1. Label-free and specific detection of soluble programmed death ligand-1 using a localized surface plasmon resonance biosensor based on excessively tilted fiber gratings.
Luo B; Wang Y; Lu H; Wu S; Lu Y; Shi S; Li L; Jiang S; Zhao M
Biomed Opt Express; 2019 Oct; 10(10):5136-5148. PubMed ID: 31646036
[TBL] [Abstract][Full Text] [Related]
2. A Dual-Channel Intelligent Point-of-Care Testing System for Soluble Programmed Death-1 and Programmed Death-Ligand 1 Detection Based on Folding Paper-Based Immunosensors.
Xing Y; Liu J; Luo J; Ming T; Yang G; Sun S; Xu S; Li X; He E; Kong F; Yan S; Yang Y; Cai X
ACS Sens; 2022 Feb; 7(2):584-592. PubMed ID: 35060694
[TBL] [Abstract][Full Text] [Related]
3. Novel optical fiber Vernier immunosensor based on cascading Sagnac loops embedded with excessively tilted fiber grating for specific detection of canine distemper virus.
Gu H; Luo B; Wu S; Shi S; Zou X; Dai Q; Zhao M; Zhang L
J Biophotonics; 2023 Apr; 16(4):e202200294. PubMed ID: 36527446
[TBL] [Abstract][Full Text] [Related]
4. A novel immunosensor based on excessively tilted fiber grating coated with gold nanospheres improves the detection limit of Newcastle disease virus.
Luo B; Xu Y; Wu S; Zhao M; Jiang P; Shi S; Zhang Z; Wang Y; Wang L; Liu Y
Biosens Bioelectron; 2018 Feb; 100():169-175. PubMed ID: 28888179
[TBL] [Abstract][Full Text] [Related]
5. Specific intracellular binding peptide as sPD-L1 antibody mimic: Robust binding capacity and intracellular region specific modulation upon applied to sensing research.
Hu J; Zhang ZH; Zhu Z; Chen J; Hu X; Chen H
Biosens Bioelectron; 2021 Aug; 185():113269. PubMed ID: 33930752
[TBL] [Abstract][Full Text] [Related]
6. Immunosensing platform with large detection range using an excessively tilted fiber grating coated with graphene oxide.
Luo B; Lu H; Shi S; Lu J; Zhao M; Wu S; Li L; Wang X; Wang Y
Appl Opt; 2018 Oct; 57(30):8805-8810. PubMed ID: 30461859
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of soluble programmed cell death-1 and soluble programmed cell death-ligand 1 in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
Tominaga T; Akiyoshi T; Yamamoto N; Taguchi S; Mori S; Nagasaki T; Fukunaga Y; Ueno M
PLoS One; 2019; 14(2):e0212978. PubMed ID: 30807610
[TBL] [Abstract][Full Text] [Related]
8. Cladding mode characteristics simulation of an excessively tilted fiber grating coated with gold nanoshells.
Liu K; Luo B; Wu D; Gu H; Yang X
Appl Opt; 2022 Jul; 61(19):5552-5558. PubMed ID: 36255781
[TBL] [Abstract][Full Text] [Related]
9. [Programmed cell death protein 1 and its ligands regulate immune balance in allergic rhinitis].
Wen SL; Li F; Zhao F; Zuo JJ; Deng YQ; Zhang W; Tao ZZ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Apr; 55(4):384-390. PubMed ID: 32306637
[No Abstract] [Full Text] [Related]
10. Serum levels of soluble programmed death protein 1 (sPD-1) and soluble programmed death ligand 1 (sPD-L1) in advanced pancreatic cancer.
Kruger S; Legenstein ML; Rösgen V; Haas M; Modest DP; Westphalen CB; Ormanns S; Kirchner T; Heinemann V; Holdenrieder S; Boeck S
Oncoimmunology; 2017; 6(5):e1310358. PubMed ID: 28638732
[TBL] [Abstract][Full Text] [Related]
11. Pre-treatment serum levels of soluble programmed cell death-ligand 1 predict prognosis in patients with hepatitis B-related hepatocellular carcinoma.
Han X; Gu YK; Li SL; Chen H; Chen MS; Cai QQ; Deng HX; Zuo MX; Huang JH
J Cancer Res Clin Oncol; 2019 Feb; 145(2):303-312. PubMed ID: 30267213
[TBL] [Abstract][Full Text] [Related]
12. Development of a microcantilever-based biosensor for detecting Programmed Death Ligand 1.
Neairat T; Al-Gawati M; Tul Ain Q; Assaifan AK; Alshamsan A; Alarifi A; Alodhayb AN; Alzahrani KE; Albrithen H
Saudi Pharm J; 2024 Jun; 32(6):102051. PubMed ID: 38812944
[TBL] [Abstract][Full Text] [Related]
13. Soluble programmed death-1 (sPD-1) and programmed death ligand 1 (sPD-L1) as potential biomarkers for the diagnosis and prognosis of glioma patients.
Liu S; Zhu Y; Zhang C; Liu J; Lv H; Zhang G; Kang X
J Med Biochem; 2020 Oct; 39(4):444-451. PubMed ID: 33312060
[TBL] [Abstract][Full Text] [Related]
14. The correlation and prognostic value of serum levels of soluble programmed death protein 1 (sPD-1) and soluble programmed death-ligand 1 (sPD-L1) in patients with hepatocellular carcinoma.
Chang B; Huang T; Wei H; Shen L; Zhu D; He W; Chen Q; Zhang H; Li Y; Huang R; Li W; Wu P
Cancer Immunol Immunother; 2019 Mar; 68(3):353-363. PubMed ID: 30506460
[TBL] [Abstract][Full Text] [Related]
15. Increase of Soluble Programmed Cell Death Ligand 1 in Patients with Chronic Hepatitis C.
Yamagiwa S; Ishikawa T; Waguri N; Sugitani S; Kamimura K; Tsuchiya A; Takamura M; Kawai H; Terai S
Int J Med Sci; 2017; 14(5):403-411. PubMed ID: 28539815
[No Abstract] [Full Text] [Related]
16. High levels of the soluble programmed death-ligand (sPD-L1) identify hepatocellular carcinoma patients with a poor prognosis.
Finkelmeier F; Canli Ö; Tal A; Pleli T; Trojan J; Schmidt M; Kronenberger B; Zeuzem S; Piiper A; Greten FR; Waidmann O
Eur J Cancer; 2016 May; 59():152-159. PubMed ID: 27039170
[TBL] [Abstract][Full Text] [Related]
17. Elevated Soluble PD-L1 in Pregnant Women's Serum Suppresses the Immune Reaction.
Okuyama M; Mezawa H; Kawai T; Urashima M
Front Immunol; 2019; 10():86. PubMed ID: 30833943
[No Abstract] [Full Text] [Related]
18. Serum levels of soluble programmed death-1 (sPD-1) and soluble programmed death ligand 1(sPD-L1) in systemic lupus erythematosus: Association with activity and severity.
Du Y; Nie L; Xu L; Wu X; Zhang S; Xue J
Scand J Immunol; 2020 Jul; 92(1):e12884. PubMed ID: 32243638
[TBL] [Abstract][Full Text] [Related]
19. Elevated levels of soluble PD-L1 are associated with reduced recurrence in papillary thyroid cancer.
Aghajani MJ; Roberts TL; Yang T; McCafferty CE; Caixeiro NJ; DeSouza P; Niles N
Endocr Connect; 2019 Jul; 8(7):1040-1051. PubMed ID: 31252406
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of soluble programmed death ligand 1 predict treatment response and progression free survival in multiple myeloma.
Wang L; Wang H; Chen H; Wang WD; Chen XQ; Geng QR; Xia ZJ; Lu Y
Oncotarget; 2015 Dec; 6(38):41228-36. PubMed ID: 26515600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
